Abstract
Aim: To determine the nature and number of suspected adverse drug reactions (ADRs) associated with fatal outcomes in children reported through the yellow card scheme.
Methods: All reports of suspected ADRs with a fatal outcome in children received by the UK Committee on Safety of Medicines through its Yellow Card Scheme from 1964 until December 2000 were reviewed. Reports associated with vaccines and overdose were excluded. The medicine, date of the report, diagnosis, ADR, and the age of the child were analysed. No formal causality assessment was performed.
Results: There were 331 deaths with 390 suspected medicines reported for children aged 16 years or less. Medicines most frequently mentioned were anticonvulsants (65 deaths), cytotoxics (34 deaths), anaesthetic agents (30 deaths), and antibiotics (29 deaths). The individual drug most frequently mentioned was sodium valproate (31 deaths). The nature of the reported ADRs were diverse, with hepatic failure the most frequent. In the past decade, there has been an increase in both the total number of suspected ADRs reported in children and the number of reports with a fatal outcome.
Conclusions: A wide range of suspected ADRs are associated with fatalities in children. Anticonvulsants were associated with the greatest number of reports of fatalities and hepatotoxicity in particular.
Full Text
The Full Text of this article is available as a PDF (99.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Appleton R. E., Farrell K., Applegarth D. A., Dimmick J. E., Wong L. T., Davidson A. G. The high incidence of valproate hepatotoxicity in infants may relate to familial metabolic defects. Can J Neurol Sci. 1990 May;17(2):145–148. doi: 10.1017/s0317167100030353. [DOI] [PubMed] [Google Scholar]
- Belay E. D., Bresee J. S., Holman R. C., Khan A. S., Shahriari A., Schonberger L. B. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med. 1999 May 6;340(18):1377–1382. doi: 10.1056/NEJM199905063401801. [DOI] [PubMed] [Google Scholar]
- Bray R. J. Propofol infusion syndrome in children. Paediatr Anaesth. 1998;8(6):491–499. doi: 10.1046/j.1460-9592.1998.00282.x. [DOI] [PubMed] [Google Scholar]
- Choonara I. Clinical trials of medicines in children. BMJ. 2000 Nov 4;321(7269):1093–1094. doi: 10.1136/bmj.321.7269.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choonara I., Dunne J. Licensing of medicines. Arch Dis Child. 1998 May;78(5):402–403. doi: 10.1136/adc.78.5.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choonara I., Gill A., Nunn A. Drug toxicity and surveillance in children. Br J Clin Pharmacol. 1996 Oct;42(4):407–410. doi: 10.1046/j.1365-2125.1996.04563.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clarkson A., Ingleby E., Choonara I., Bryan P., Arlett P. A novel scheme for the reporting of adverse drug reactions. Arch Dis Child. 2001 Apr;84(4):337–339. doi: 10.1136/adc.84.4.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dreifuss F. E., Santilli N., Langer D. H., Sweeney K. P., Moline K. A., Menander K. B. Valproic acid hepatic fatalities: a retrospective review. Neurology. 1987 Mar;37(3):379–385. doi: 10.1212/wnl.37.3.379. [DOI] [PubMed] [Google Scholar]
- Hughes J., Gill A., Leach H. J., Nunn A. J., Billingham I., Ratcliffe J., Thornington R., Choonara I. A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatr. 1994 Nov;83(11):1194–1199. doi: 10.1111/j.1651-2227.1994.tb18280.x. [DOI] [PubMed] [Google Scholar]
- Impicciatore P., Choonara I., Clarkson A., Provasi D., Pandolfini C., Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001 Jul;52(1):77–83. doi: 10.1046/j.0306-5251.2001.01407.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McGovern M. C., Glasgow J. F., Stewart M. C. Lesson of the week: Reye's syndrome and aspirin: lest we forget. BMJ. 2001 Jun 30;322(7302):1591–1592. doi: 10.1136/bmj.322.7302.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norris E., Marzouk O., Nunn A., McIntyre J., Choonara I. Respiratory depression in children receiving diazepam for acute seizures: a prospective study. Dev Med Child Neurol. 1999 May;41(5):340–343. doi: 10.1017/s0012162299000742. [DOI] [PubMed] [Google Scholar]
- Parke T. J., Stevens J. E., Rice A. S., Greenaway C. L., Bray R. J., Smith P. J., Waldmann C. S., Verghese C. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ. 1992 Sep 12;305(6854):613–616. doi: 10.1136/bmj.305.6854.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patel L., Wales J. K., Kibirige M. S., Massarano A. A., Couriel J. M., Clayton P. E. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child. 2001 Oct;85(4):330–334. doi: 10.1136/adc.85.4.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raju T. N., Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. J Pediatr. 1993 Oct;123(4):603–610. doi: 10.1016/s0022-3476(05)80963-1. [DOI] [PubMed] [Google Scholar]
- Starko K. M., Ray C. G., Dominguez L. B., Stromberg W. L., Woodall D. F. Reye's syndrome and salicylate use. Pediatrics. 1980 Dec;66(6):859–864. [PubMed] [Google Scholar]
- WEISS C. F., GLAZKO A. J., WESTON J. K. Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med. 1960 Apr 21;262:787–794. doi: 10.1056/NEJM196004212621601. [DOI] [PubMed] [Google Scholar]
- Waller P. C., Coulson R. A., Wood S. M. Regulatory pharmacovigilance in the United Kingdom: current principles and practice. Pharmacoepidemiol Drug Saf. 1996 Nov;5(6):363–375. doi: 10.1002/(SICI)1099-1557(199611)5:6<363::AID-PDS249>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]